Surmodics reported $26.26M in Operating Expenses for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Abbott ABT:US $ 8881M 534M
Align Technology ALGN:US $ 741.91M 72.58M
Anika Therapeutics ANIK:US $ 28.96M 4.07M
Arrowhead Research ARWR:US $ 77.76M 16.72M
Baxter International BAX:US $ 2674M 118M
Bioscrip BIOS:US $ 812.18M 94.44M
Boston Scientific BSX:US $ 2815M 433M
Cryolife CRY:US $ 74.82M 5.18M
Edap Tms EDAP:US 10.78M 714K
Edwards Lifesciences EW:US $ 833.9M 0.8M
Genmark Diagnostics GNMK:US $ 52.17M 8.25M
Haemonetics HAE:US $ 227.14M 19.07M
Heron Therapeutics HRTX:US $ 82.91M 10.78M
Johnson & Johnson JNJ:US $ 16.65B 1.76B
Merit Medical Systems MMSI:US $ 271.43M 36.71M
Mesa Laboratories MLAB:US $ 31.8M 1.87M
Nektar Therapeutics NKTR:US $ 138.54M 5.5M
Oxford Immunotec Global OXFD:US 19.16M 3.49M
Providence Service PRSC:US $ 446.88M 22.08M
Stryker SYK:US $ 3.57B 82M
Surmodics SRDX:US $ 26.26M 745K